Denali Therapeutics Inc. Shares Outstanding (Cover Page)
Denali Therapeutics Inc. (DNLI) had Shares Outstanding (Cover Page) of 159.85 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 159.85M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 158.71M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 158.59M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 146.66M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 159.85M shares 10-Q · filed 2026-08-06 |
| 2026-05-01 | 158.71M shares 10-Q · filed 2026-05-07 |
| 2026-02-20 | 158.59M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 146.66M shares 10-Q · filed 2025-11-06 |
| 2025-08-05 | 146.21M shares 10-Q · filed 2025-08-11 |
| 2025-04-30 | 145.28M shares 10-Q · filed 2025-05-06 |
| 2025-02-21 | 145.22M shares 10-K · filed 2025-02-27 |
| 2024-10-30 | 143.92M shares 10-Q · filed 2024-11-06 |
| 2024-07-25 | 143.17M shares 10-Q · filed 2024-08-01 |
| 2024-04-30 | 142.61M shares 10-Q · filed 2024-05-07 |
| 2024-02-20 | 139.16M shares 10-K · filed 2024-02-28 |
| 2023-10-30 | 138.20M shares 10-Q · filed 2023-11-07 |
| 2023-07-31 | 137.42M shares 10-Q · filed 2023-08-08 |
| 2023-05-01 | 136.89M shares 10-Q · filed 2023-05-08 |
| 2023-02-21 | 136.68M shares 10-K · filed 2023-02-27 |
| 2022-10-27 | 135.81M shares 10-Q · filed 2022-11-03 |
| 2022-08-01 | 123.35M shares 10-Q · filed 2022-08-08 |
| 2022-04-28 | 122.95M shares 10-Q · filed 2022-05-05 |
| 2022-02-18 | 122.83M shares 10-K · filed 2022-02-28 |
| 2021-10-29 | 122.13M shares 10-Q · filed 2021-11-04 |
| 2021-07-28 | 121.64M shares 10-Q · filed 2021-08-04 |
| 2021-04-26 | 121.19M shares 10-Q · filed 2021-05-05 |
| 2021-02-17 | 120.98M shares 10-K · filed 2021-02-26 |
| 2020-10-28 | 119.92M shares 10-Q · filed 2020-11-05 |
| 2020-08-03 | 105.98M shares 10-Q · filed 2020-08-07 |
| 2020-04-29 | 105.63M shares 10-Q · filed 2020-05-07 |
| 2020-02-19 | 105.42M shares 10-K · filed 2020-02-27 |
| 2019-10-30 | 96.03M shares 10-Q · filed 2019-11-06 |
| 2019-07-31 | 95.84M shares 10-Q · filed 2019-08-06 |
| 2019-05-01 | 95.48M shares 10-Q · filed 2019-05-08 |
| 2019-03-05 | 95.29M shares 10-K · filed 2019-03-12 |
| 2018-11-02 | 94.96M shares 10-Q · filed 2018-11-08 |
| 2018-08-02 | 94.81M shares 10-Q · filed 2018-08-09 |
| 2018-05-04 | 94.44M shares 10-Q · filed 2018-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |